文献速递呼吸道感染

新型冠状病毒肺炎预后临床预测评分研究进展

[Advances in clinical prediction scores for prognosis of coronavirus disease-2019].
PubMed 文献 · Zhonghua Jie He He Hu Xi Za Zhi · 2022-01-01

本文综述了用于评估COVID-19不良预后风险的多种临床预测评分,包括基于社区获得性肺炎、脓毒症和病毒性肺炎的常用评分。文章指出这些评分普遍存在适用人群描述不足、偏倚风险高及适用性不明等问题,旨在为临床预后风险评估提供参考。

要点

  • COVID-19以轻型、普通型多见,重型-危重型病死率明显升高且所需医疗资源更多。
  • 多种基于其他疾病及COVID-19的评分被用于不良预后风险评估。
  • 现有评分普遍存在通用性、适用性不明及高偏倚风险。

核心结论

  • 现有用于COVID-19不良预后风险评估的评分普遍存在适用人群描述不足、偏倚风险高和适用性不明的问题。

研究设计与样本

  • 本文为综述,归纳总结了现有基于其他疾病及COVID-19的预后评分。

主要发现

  • COVID-19以轻型、普通型多见,重型-危重型比例较小但病死率明显升高且所需医疗资源更多。
  • 用于COVID-19不良预后评估的评分包括社区获得性肺炎、脓毒症和病毒性肺炎等常用评分。

临床怎么用

  • 临床可参考本文归纳的现有评分进行COVID-19不良预后风险评估,但需注意其适用性不明和高偏倚风险。

局限性

  • 所综述的评分普遍缺乏对适用人群的充分描述,且存在高偏倚风险和适用性不明的问题。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Coronavirus Disease-2019 (COVID-19) has been a major public health issue all over the world, placing a significant burden on available healthcare resources. The most common types of COVID-19 are the mild and common forms. Although the proportion of the severe-critical types is smaller, the rate of death is significantly higher and the medical resources required tend to be greater. Thus, a variety of scores based on other disease and COVID-19 were used to assess the risk of poor prognosis on the COVID-19, including the common scores for community-acquired pneumonia, sepsis and viral pneumonia. Unfortunately, the above scores often lacked an adequate description of the applicable population or were at high risk of bias with unknown applicability. Therefore, the article summarized the existing scores, aiming to provide a reference for clinical prognostic risk assessment. 新型冠状病毒肺炎(coronavirus disease-2019,COVID-19)已成为全球重大公共卫生事件,对现有医疗资源造成重大负担。COVID-19以轻型、普通型多见,重型-危重型所占比例虽然较少,但病死率明显升高,所需医疗资源也往往更多。多种基于其他疾病及COVID-19的评分被用于COVID-19不良预后风险的评估,其中包含社区性肺炎、病毒性肺炎、脓毒症早期识别等常用评分。但上述评分普遍存在通用性、适用性不明,高偏倚等风险。本文将对现有COVID-19评分进行归纳、总结,旨在为临床不良预后风险评估提供参考。.

来源:Zhonghua Jie He He Hu Xi Za Zhi,查看原文。版权归原作者所有。

引用

  1. Cai, Zeng, Li, et al. [Advances in clinical prediction scores for prognosis of coronavirus disease-2019]. Zhonghua Jie He He Hu Xi Za Zhi. 2022. PMID: 35768378. doi:10.3760/cma.j.cn112147-20211125-00837

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。